Cerebrovascular diseases are a group of condition characterized by a certain dysfunction of blood vessels supplying the brain and also affect the flow of blood in an individual’s brain. For proper functioning of the brain, it needs certain nutrients and oxygen from the arteries. However, if there is any kind of restriction in the blood flow, the brain cells begin to die. The prime causes of cerebrovascular disease are cerebral thrombosis, cerebral embolism, and cerebral hemorrhage. Due to cerebrovascular disease, part of the brain is affected due to bleeding and thereby leads to different types of cerebrovascular diseases such as stroke, transient ischaemic attack (TIA), vascular dementia, and subarachnoid hemorrhage.
According to Centers for Disease Control and Prevention, cerebrovascular disease is the fourth most common cause of death in the U.S. Following North America, European countries are also expected to show steady growth in the market. In the next few years, Asia-Pacific would show remarkable growth in the cerebrovascular disease market as it is developing at a very rapid pace. The factors which would fuel the growth of the market in Asia Pacific are increasing awareness about cerebrovascular disease, certain family history related to the disease and rapidly developing technologically advanced treatments.
In 2018, the global Cerebrovascular Disease market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Cerebrovascular Disease status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Cerebrovascular Disease development in United States, Europe and China.
The key players covered in this study
Johnson & Johnson
Market segment by Type, the product can be split into
Carotid Angioplasty Or Carotid Artery Stenting
Drug Medication (Aspirin, Ticlopidine, And Sulfinpyrazone)
Market segment by Application, split into
Academic & Research Institutes
Pharmaceutical & Biotechnology Companies
Hospitals & Diagnostic Centers
Contract Research Organizations
Market segment by Regions/Countries, this report covers
Central & South America
The study objectives of this report are:
To analyze global Cerebrovascular Disease status, future forecast, growth opportunity, key market and key players.
To present the Cerebrovascular Disease development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Cerebrovascular Disease are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.